COVID-19 vaccine introduction: Insights from malaria, meningitis, and more

Organized by PATH  COVID-19 vaccine introduction: Insights from malaria, meningitis, and more December 3, 2020 RSVP As COVID-19 vaccines become available, the world must have the infrastructure, supply chains, and distributions plans in place to introduce the vaccines at unprecedented scale and speed. What have we learned from past vaccine implementations that can guide an…

Read More

GHC statement on the Global Vaccine Action Plan at the 73rd World Health Assembly

Global Health Council was unable to submit statements on all (or some) official agenda items. Global Health Council, in collaboration with partners, note the following: We commend the World Health Organization and Member States on progress made toward global immunization targets. Despite these efforts, coverage of essential vaccines only increased from 84 to 86 percent…

Read More

Engaging civil society to support equitable access to COVID-19 vaccines

Organized by Johns Hopkins Bloomberg School of Public Health International Vaccine Access Center Engaging civil society to support equitable access to COVID-19 vaccines October 21, 2020 RSVP Vaccines will be an important way to mitigate the pandemic, but they will not likely be available to everyone in all countries for several years. COVAX, co-led by…

Read More

How will a COVID-19 Vaccine be Delivered?

Organized by Johns Hopkins Bloomberg School of Public Health International Vaccine Access Center How will a COVID-19 Vaccine be Delivered? June 17, 2020 RSVP When a COVID-19 vaccine becomes available, it will effectively stop disease transmission only if it reaches the people who need it. Many decisions go into developing a strategy for the delivery of…

Read More

GSK and MVI Announce Promising Malaria Vaccine Trial Results

Last week GlaxoSmithKline (GSK), one of the world’s leading research-based pharmaceutical and healthcare companies and the PATH Malaria Vaccine Intiative (MVI), announced that the world may be closer to a malaria vaccine than once thought.  Working together, MVI and GSK announced results from a large scale trail in Africa testing the RTS,S vaccine which demonstrated…

Read More

Bill Gates: Charting a Course to End Malaria

As the Gates Foundation hosts a global forum on malaria, Bill Gates commits to the eradication of the disease. In the past 10 years, the number of people who die from malaria has declined 20 percent. For the past three days, the global malaria community has been meeting in Seattle, talking about what it’s going…

Read More

Major Milestone in Malaria: RTS,S Vaccine Within Reach

An interview with researchers integral to the success of this large-scale RTS,S vaccine trial: The first set of results from the large-scale Phase 3 efficacy trial of the world’s most clinically advanced malaria vaccine candidate, RTS,S, were published today in the New England Journal of Medicine (NEJM) and announced at the Malaria Forum in Seattle,…

Read More

We Started! The First Child in Sudan to Receive a Rotavirus Vaccine

This is a guest blog by Dr. Amani Abdelmoniem Mustafa, manager of the Expanded Programme on Immunization for Sudan. KHARTOUM, Sudan — The day that we were waiting for arrived. The children of Sudan have long suffered terrible, sometimes deadly, diarrhea caused by rotavirus. Fortunately, there is a vaccine that can save our children from so much…

Read More